| Upcoming events on ROCHE HOLDING AG |
|
| 01/28/21 | | International Association for the Study of Lung Cancer World Conference |
| 02/04/21 | 07:00am | | Jahr 2020 Ergebnisveröffentlichung |
| 02/04/21 | 02:00pm | | Jahr 2020 Präsentation des Ergebnisses |
| 02/17/21 | | Citi Immuno-oncology Leadership Summit |
|
| Past events on ROCHE HOLDING AG |
|
| 01/17/21 | 09:30pm | | American Society of Clinical Oncology Virtual Gastrointestinal Cancers Symposium |
| 01/14/21 | | Octavian Seminar |
| 01/11/21 | | JP Morgan Healthcare Conference |
| 12/24/20 | | Jefferies Global Healthcare Conference |
|
| Upcoming sector events for ROCHE HOLDING AG |
|
|
| |
|
| Past sector events for ROCHE HOLDING AG |
|
|
|
|
|
| Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales
M CHF |
Released
Forecast
Spread | 48 145
47 916
0,48% | 50 576
50 686
-0,22% | 53 299
53 126
0,33% | 56 846
56 448
0,70% | 61 466
61 789
-0,52% |
59 276
|
Operating income
(EBITDA)
M CHF |
Released
Forecast
Spread | 19 558
19 548
0,05% | 20 483
20 420
0,31% | 21 201
20 725
2,3% | 22 825
22 398
1,9% | 25 419
24 199
5,0% |
24 525
|
Operating profit
(EBIT)
M CHF |
Released
Forecast
Spread | 17 542
17 340
1,2% | 18 420
18 651
-1,2% | 19 012
19 361
-1,8% | 20 505
20 431
0,36% | 22 479
22 680
-0,89% |
21 621
|
Pre-Tax Profit
(EBT)
M CHF |
Released
Forecast
Spread | 11 987
14 023
-15% | 13 007
14 865
-12% | 12 248
14 738
-17% | 14 148
17 012
-17% | 16 614
18 369
-9,6% |
18 289
|
Net income
M CHF |
Released
Forecast
Spread | 8 863
10 434
-15% | 9 576
10 611
-9,8% | 8 633
10 674
-19% | 10 500
12 780
-18% | 13 497
14 257
-5,3% |
14 335
|
EPS
CHF |
Released
Forecast
Spread | 10,3
12,1
-15% | 11,1
12,6
-12% | 10,0
12,5
-20% | 12,2
15,3
-20% | 15,6
16,6
-5,7% |
16,5
| | Announcement Date | 01/28/2016 | 02/01/2017 | 02/01/2018 | 01/31/2019 | 01/30/2020 | |
|
|
|
| Quarterly results | 2015 S2 | 2016 S1 | 2016 S2 | 2017 S1 | 2017 S2 | 2018 Q1 | 2018 Q2 | 2018 S1 | 2018 Q3 | 2018 Q4 | 2018 S2 | 2019 Q1 | 2019 Q2 | 2019 S1 | 2019 Q3 | 2019 Q4 | 2019 S2 | 2020 Q1 | 2020 Q2 | 2020 S1 | 2020 Q3 (e) | 2020 Q4 (e) | 2020 S2 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 S1 (e) | 2021 S2 (e) | 2022 S1 (e) | 2022 S2 (e) |
Sales
M CHF |
Released
Forecast
Spread | 24 560
24 251
1,3% | 25 020
24 829
0,77% | 26 000
25 660
1,3% | 26 344
26 127
0,83% | 26 955
26 762
0,72% | 13 583
13 385
1,5% | 14 528
14 015
3,7% | 28 111
27 568
2,0% | 13 969
13 830
1,0% | 14 766
14 534
1,6% | 28 735
28 366
1,3% | 14 826
14 390
3,0% | 15 643
15 467
1,1% | 30 469
30 275
0,64% | 15 597
15 083
3,4% | 15 400
15 852
-2,8% | 30 997
31 426
-1,4% | 15 143
14 736
2,8% | 14 138
14 989
-5,7% | 29 281
30 369
-3,6% |
15 091
|
15 152
|
30 126
|
15 377
|
15 183
|
15 648
|
29 457
|
32 008
|
31 575
|
33 135
|
Operating income
(EBITDA)
M CHF |
Released
Forecast
Spread | 9 390
8 237
14% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating profit
(EBIT)
M CHF |
Released
Forecast
Spread | 8 306
8 281
0,30% | 9 850
9 608
2,5% | 8 570
8 714
-1,7% | 10 135
9 914
2,2% | 8 877
9 153
-3,0% |
|
| 11 162
10 480
6,5% |
|
| 9 343
9 269
0,80% |
|
| 12 363
11 862
4,2% |
|
| 10 116
10 525
-3,9% |
|
| 11 766
11 824
-0,49% |
|
|
9 893
|
|
|
|
|
|
|
|
Pre-Tax Profit
(EBT)
M CHF |
Released
Forecast
Spread | 4 907
6 783
-28% |
|
|
|
|
|
|
|
|
| 4 654
8 143
-43% |
|
| 10 354
11 145
-7,1% |
|
| 6 260
9 758
-36% |
|
| 10 181
10 632
-4,2% |
|
|
9 124
|
|
|
|
|
|
|
|
Net income
M CHF |
Released
Forecast
Spread | 3 709
5 176
-28% | 5 378
6 022
-11% |
| 5 477
6 764
-19% |
|
|
|
|
|
| 3 191
6 551
-51% |
|
| 8 619
8 910
-3,3% |
|
| 4 878
6 896
-29% |
|
| 8 079
8 713
-7,3% |
|
|
7 084
|
|
|
|
|
|
|
|
EPS
|
Released
Forecast
Spread | 4,30
6,16
-30% | 6,24
7,28
-14% | 4,89
6,40
-24% | 6,37
7,06
-9,7% | 3,67
6,38
-42% |
|
| 8,51
8,26
3,0% |
|
| 3,70
7,29
-49% |
|
| 9,99
9,66
3,4% |
|
| 5,63
7,56
-26% |
|
| 9,32
9,70
-3,9% |
|
|
8,24
|
|
|
|
|
|
|
| | Announcement Date | 01/28/2016 | 07/21/2016 | 02/01/2017 | 07/27/2017 | 02/01/2018 | 04/26/2018 | 07/26/2018 | 07/26/2018 | 10/17/2018 | 01/31/2019 | 01/31/2019 | 04/17/2019 | 07/25/2019 | 07/25/2019 | 10/16/2019 | 01/30/2020 | 01/30/2020 | 04/22/2020 | 07/23/2020 | 07/23/2020 | | | | | | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
|
AstraZeneca shares fall on 'hefty' $39-billion Alexion deal |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
